Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators. (1st May 2021)
- Record Type:
- Journal Article
- Title:
- Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators. (1st May 2021)
- Main Title:
- Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators
- Authors:
- Theuns, Dominic A.M.J.
Schaer, Beat A.
Caliskan, Kadir
Hoeks, Sanne E.
Sticherling, Christian
Yap, Sing-Chien
Alba, Ana Carolina - Abstract:
- Abstract: Background: The Heart Failure (HF) Meta-score may be useful in predicting prognosis in patients with primary prevention cardiac resynchronization defibrillators (CRT-D) considering the competing risk of appropriate defibrillator shock versus mortality. Methods: Data from 648 consecutive patients from two centers were used for the evaluation of the performance of the HF Meta-score. The primary endpoint was mortality and the secondary endpoint was time to first appropriate implantable cardioverter-defibrillator (ICD) shock or death without prior appropriate ICD shock. Fine-Gray model was used for competing risk regression analysis. Results: In the entire cohort, 237 patients died over a median follow-up of 5.2 years. Five-year cumulative incidence of mortality ranged from 12% to 53%, for quintiles 1 through 5 of the HF Meta-score, respectively (log-rank P < 0.001). Compared with the lowest quintile, mortality risk was higher in the highest quintile (HR 6.9; 95%CI 3.7–12.8). The HF Meta-score had excellent calibration, accuracy, and good discrimination in predicting mortality ( C -statistic 0.76 at 1-year and 0.71 at 5-year). The risk of death without appropriate ICD shock was higher in risk quintile 5 compared to quintile 1 (sub HR 5.8; 95%CI 3.1–11.0, P < 0.001). Conclusions: Our study demonstrated a good ability of the HF Meta-score to predict survival in HF patients treated with CRT-D as primary prevention. The HF Meta-score proved to be useful in identifying aAbstract: Background: The Heart Failure (HF) Meta-score may be useful in predicting prognosis in patients with primary prevention cardiac resynchronization defibrillators (CRT-D) considering the competing risk of appropriate defibrillator shock versus mortality. Methods: Data from 648 consecutive patients from two centers were used for the evaluation of the performance of the HF Meta-score. The primary endpoint was mortality and the secondary endpoint was time to first appropriate implantable cardioverter-defibrillator (ICD) shock or death without prior appropriate ICD shock. Fine-Gray model was used for competing risk regression analysis. Results: In the entire cohort, 237 patients died over a median follow-up of 5.2 years. Five-year cumulative incidence of mortality ranged from 12% to 53%, for quintiles 1 through 5 of the HF Meta-score, respectively (log-rank P < 0.001). Compared with the lowest quintile, mortality risk was higher in the highest quintile (HR 6.9; 95%CI 3.7–12.8). The HF Meta-score had excellent calibration, accuracy, and good discrimination in predicting mortality ( C -statistic 0.76 at 1-year and 0.71 at 5-year). The risk of death without appropriate ICD shock was higher in risk quintile 5 compared to quintile 1 (sub HR 5.8; 95%CI 3.1–11.0, P < 0.001). Conclusions: Our study demonstrated a good ability of the HF Meta-score to predict survival in HF patients treated with CRT-D as primary prevention. The HF Meta-score proved to be useful in identifying a subgroup with a significantly poor prognosis despite a CRT-D. Highlights: The Heart Failure Meta-score reliably predicts survival in patients who received a CRT-D as primary prevention of SCD. The Heart Failure Meta-score is able to discriminate between patients with a low or high risk for mortality The majority of patients died without experiencing an appropriate ICD shock The Heart Failure Meta-score can be used to identify a subgroup with a significantly poor prognosis despite a CRT-D … (more)
- Is Part Of:
- International journal of cardiology. Volume 330(2021)
- Journal:
- International journal of cardiology
- Issue:
- Volume 330(2021)
- Issue Display:
- Volume 330, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 330
- Issue:
- 2021
- Issue Sort Value:
- 2021-0330-2021-0000
- Page Start:
- 73
- Page End:
- 79
- Publication Date:
- 2021-05-01
- Subjects:
- Implantable cardioverter-defibrillator -- Cardiac resynchronization therapy -- Primary prevention -- Risk stratification -- Mortality
Cardiology -- Periodicals
Electronic journals
616.12 - Journal URLs:
- http://www.clinicalkey.com/dura/browse/journalIssue/01675273 ↗
http://www.sciencedirect.com/science/journal/01675273 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijcard.2021.01.011 ↗
- Languages:
- English
- ISSNs:
- 0167-5273
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.158000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25093.xml